Patents by Inventor Michelle F. WALDMAN

Michelle F. WALDMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CEREBLON ISOFORMS AND THEIR USE AS BIOMARKERS FOR THERAPEUTIC TREATMENT
    Publication number: 20170362660
    Abstract: Provided herein are cereblon isoforms and methods of their use as biomarkers for treating a disease, disorder, or condition with a treatment compound, e.g., thalidomide, lenalidomide, pomalidomide, 3-(5-amino-2-methyl-4-oxoquinazolin-3 (4H)-yl)-piperidine-2,6-dione, or (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione.
    Type: Application
    Filed: January 24, 2017
    Publication date: December 21, 2017
    Inventors: Anjan THAKURTA, Anita GANDHI, Michelle F. WALDMAN, Rajesh CHOPRA, Michael AMATANGELO, Chad BJORKLUND
  • Cereblon isoforms and their use as biomarkers for therapeutic treatment
    Patent number: 9587281
    Abstract: Provided herein are cereblon isoforms and methods of their use as biomarkers for treating a disease, disorder, or condition with a treatment compound, e.g., thalidomide, lenalidomide, pomalidomide, 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)-piperidine-2,6-dione, or (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione.
    Type: Grant
    Filed: February 12, 2015
    Date of Patent: March 7, 2017
    Assignee: CELGENE CORPORATION
    Inventors: Anjan Thakurta, Anita Gandhi, Michelle F. Waldman, Rajesh Chopra, Michael Amatangelo, Chad Bjorklund
  • CEREBLON ISOFORMS AND THEIR USE AS BIOMARKERS FOR THERAPEUTIC TREATMENT
    Publication number: 20150152511
    Abstract: Provided herein are cereblon isoforms and methods of their use as biomarkers for treating a disease, disorder, or condition with a treatment compound, e.g., thalidomide, lenalidomide, pomalidomide, 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)-piperidine-2,6-dione, or (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione.
    Type: Application
    Filed: February 12, 2015
    Publication date: June 4, 2015
    Inventors: Anjan THAKURTA, Anita GANDHI, Michelle F. WALDMAN, Rajesh CHOPRA, Michael AMATANGELO, Chad BJORKLUND